Safety of pulmonary administration of gemcitabine in rats

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 18, Issue 2, 2005, Pages 198-206

  Gagnadoux, Frédéric ^a,b   Le Pape, Alain ^a,c   Urban, Thierry ^b   Montharu, Jérome ^a   Vecellio, Laurent ^a   Dubus, Jean Christophe ^a   Leblond, Valérie ^a   Diot, Patrice ^a   Grimbert, Daniel ^a   Racineux, Jean Louis ^b   Lemarié, Etienne ^a  

^a INSERM   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c BiopharmConsulting   (France)

Author keywords

Aerosol; Chemotherapy; Gemcitabine; Pulmonary deposition; Rat; Toxicity

Indexed keywords

GEMCITABINE;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; DRUG SAFETY; DRUG SCREENING; FEMALE; HISTOPATHOLOGY; MAXIMUM TOLERATED DOSE; NONHUMAN; RAT; TRACHEOBRONCHIAL TOILET;

EID: 21344435041     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2005.18.198     Document Type: Article

References (15)

1. Minchin, R.F., M.R. Johnston, H.M. Schuller, et al. 1988. Pulmonary toxicity of doxorubicin administered by in situ isolated lung perfusion in dogs. Cancer 61:1320-1325.
2. Ng, B., J.T. Lenert, B. Weksler, et al. 1995. Isolate lung perfusion with FUDR is an effective treatment for colorectal adenocarcinoma lung metastases in rats. Ann. Thorac. Surg. 59:205-208.
3. Van Putte, B.P., J.M. Hendriks, S. Romijn, et al. 2003. Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survival. J. Surg. Res. 109:118-122.
4. Lipworth, B.J. 1996. Pharmacokinetics of inhaled drugs. Br. J. Clin. Pharmacol. 42:697-705.
5. Tatsumura, T., S. Koyama, M. Tsujimoto, et al. 1993. Further study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: fundamental and clinical. Br. J. Cancer 68:1146-1149.
6. Hershey, A.E., I.D. Kurman, L.J. Forrest, et al. 1999. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model. Clin. Cancer Res. 5:2653-2659.
7. Sharma, S., D. White, A.R. Imondy, et al. 2001. Development of inhalational agents for oncologic use. J. Clin. Oncol. 19:1839-1847.
8. Perng, R.P., Y.M. Cheng, J. Ming-Lui, et al. 1997. Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study. J. Clin. Oncol. 15:2097-2102.
9. Mackey, J.R., R.S. Mani, M. Seiner, et al. 1998. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res. 58:4349-4357.
10. Pestieau, S.R., O.A. Stuart, D. Chang, et al. 1998. Pharmacokinetics of intraperitoneal gemcitabine in a rat model. Tumori 84:706-711.
11. Egorin, M.J., E.G. Zuhowski, C.M. McCully, et al. 2002. Pharmacokinetics of intrathecal gemcitabine in nonhuman primates. Clin. Cancer Res. 8:2437-2442.
12. Miot-Noirault, E., L. Faure, Y. Guichard, et al. 2001. Scintigraphic in vivo assessment of the development of pulmonary intravascular macrophages in liver disease. Experimental study in rats with biliary cirrhosis. Chest 120:941-947.
13. Selig, W., D. Bissantz, C. Burgos-Lepley, et al. 1996. Effect of the orally-active human neutrophil elastase inhibitor, MDL 101-146, on hne-induced lung injury in the rat. Am. J. Respir. Crit. Care Med. 153:A398.
14. Isitman, A.T., B.D. Collier, D.W. Palmer, et al. 1998. Comparison of technetium-99m pyrophosphate and technetium-99m DTPA aerosols for SPECT ventilation imaging. J. Nucl. Med. 29:1761-1767.
15. Kaway, M., Y. Esumi, S. Ishizaki, et al. 1995. Metabolism of gemcitabine in rat and dogs. Xenobiotica 25:405-416.